Form CORRESP - Correspondence:
SEC Accession No. 0001144204-19-006201
Filing Date
2019-02-11
Accepted
2019-02-11 14:30:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 37912
2 GRAPHIC image_001.jpg GRAPHIC 3369
  Complete submission text file 0001144204-19-006201.txt   43774
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations